- Home
- CHRS vs VIRC Comparison
CHRS vs VIRC Comparison
Compare CHRS & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- VIRC
- Stock Information
- Founded
- CHRS 2010
- VIRC 1950
- Country
- CHRS United States
- VIRC United States
- Employees
- CHRS N/A
- VIRC N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- VIRC Industrial Specialties
- Sector
- CHRS Health Care
- VIRC Consumer Discretionary
- Exchange
- CHRS Nasdaq
- VIRC Nasdaq
- Market Cap
- CHRS 194.1M
- VIRC 105.4M
- IPO Year
- CHRS 2014
- VIRC N/A
- Fundamental
- Price
- CHRS $1.61
- VIRC $7.37
- Analyst Decision
- CHRS Strong Buy
- VIRC
- Analyst Count
- CHRS 4
- VIRC 0
- Target Price
- CHRS $4.51
- VIRC N/A
- AVG Volume (30 Days)
- CHRS 958.4K
- VIRC 76.1K
- Earning Date
- CHRS 11-07-2025
- VIRC 12-08-2025
- Dividend Yield
- CHRS N/A
- VIRC 1.34%
- EPS Growth
- CHRS N/A
- VIRC N/A
- EPS
- CHRS 1.55
- VIRC 0.84
- Revenue
- CHRS $272,209,000.00
- VIRC $236,926,000.00
- Revenue This Year
- CHRS N/A
- VIRC $0.81
- Revenue Next Year
- CHRS $109.48
- VIRC $4.56
- P/E Ratio
- CHRS $1.03
- VIRC $8.78
- Revenue Growth
- CHRS 52.33
- VIRC N/A
- 52 Week Low
- CHRS $0.66
- VIRC $6.65
- 52 Week High
- CHRS $2.43
- VIRC $17.31
- Technical
- Relative Strength Index (RSI)
- CHRS 50.10
- VIRC 47.20
- Support Level
- CHRS $1.64
- VIRC $7.31
- Resistance Level
- CHRS $1.82
- VIRC $7.61
- Average True Range (ATR)
- CHRS 0.10
- VIRC 0.25
- MACD
- CHRS -0.03
- VIRC 0.07
- Stochastic Oscillator
- CHRS 8.33
- VIRC 73.68
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.